<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Regeneron, Sanofi get marketing authorization for Dupixent from MHLW in Japan

PremiumThe Fly

13h ago

Government deals lift overhang on pharma group, says BofA

REGN

PremiumThe Fly

1d ago

Trump announces pacts with nine pharma companies to lower drug prices

PremiumThe Fly

4d ago

Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports

GSK

PremiumThe Fly

4d ago

PremiumThe FlySanofi anticipates delay in U.S. regulatory review of tolebrutinib in nrSPMS

9d ago

Sanofi says tolebrutinib did not meet primary endpoint in PERSEUS phase 3 study

The Fly

Sanofi says tolebrutinib did not meet primary endpoint in PERSEUS phase 3 study

9d ago

Sanofi: Buy Rating Maintained Amid Attractive Valuation and Long-Term Growth Potential Despite Pipeline Setbacks

Ratings

Sanofi: Buy Rating Maintained Amid Attractive Valuation and Long-Term Growth Potential Despite Pipeline Setbacks

9d ago

Sanofi says Qfitlia, Cablivi approved in China for rare hematologic diseases

PremiumThe Fly

13d ago

Sanofi price target lowered to EUR 100 from EUR 102 at HSBC

PremiumThe Fly

14d ago

Guggenheim downgrades Sanofi on lack of near-term pipeline catalysts

PremiumThe Fly

14d ago

Sanofi downgraded to Neutral from Buy at Guggenheim

PremiumThe Fly

15d ago

PremiumThe FlySanofi downgraded to Neutral from Overweight at JPMorgan

16d ago

Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’

The Fly

Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’

18d ago

FDA shift in drug study requirements sends trial runners lower

The Fly

FDA shift in drug study requirements sends trial runners lower

19d ago

FDA to reduce number of trials required for drug approvals, STAT reports

PremiumThe Fly

19d ago

FDA to reduce number of trials required for drug approvals, STAT reports

PremiumThe Fly

19d ago

Top drug regulator Richard Pazdur preparing to exit FDA, STAT News reports

PremiumThe Fly

21d ago

Vaccine committee considers changes to childhood schedule, NY Times reports

PremiumThe Fly

22d ago

PremiumThe FlyMidday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK

22d ago

Prasad email a headwind for vaccine manufacturers, says BofA

The Fly

Prasad email a headwind for vaccine manufacturers, says BofA

22d ago

GSK

PFE

Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing

The Fly

Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing

22d ago